JNJ - Johnson & Johnson

Day 1m 10m 60m PreMarket Market AfterHours Gap
189.96 0.96 (0.51%) --- --- --- 1.11 (0.58%) -0.31 (-0.16%) -0.25 (-0.13%) -0.25 (-0.13%)

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
2.3
Diluted EPS:
2.29
Basic P/E:
83.0087
Diluted P/E:
83.3712
RSI(14) 1m:
100.0
VWAP:
190.92
RVol:
0.8681

Events

Period Kind Movement Occurred At

Related News